EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Outcomes of Highly Urgent ABO-Incompatible Living Donor Liver Transplantation in National Databases

Jongman Kim iD, Sang Jin Kim iD, Boram Park iD, Kyunga Kim iD, YoungRok Choi iD, Geun Hong iD, Jun Yong Park iD, Young Seok Han iD, Nam-Joon Yi iD, Seung Heui Hong iD, Soon-Young Kim iD, Jungbun Park iD und 2 weitere

Journal of Korean Medical Science · 2026

DOI: 10.3346/jkms.2026.41.e46 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Korean Medical Science, 2026. Verfasst von Jongman Kim und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. yjongman21@gmail.com. Hauptthemen laut MEDLINE: Liver Transplantation, Living Donors, ABO Blood-Group System, Blood Group Incompatibility. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Health and Welfare, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Highly urgent adult living donor liver transplantation (HU-LDLT) is essential for patients with acute liver failure (ALF), acute-on-chronic liver failure (ACLF), and severe cirrhosis who are in life-threatening situations. The results of adult highly urgent ABO-incompatible (ABOi) living donor liver transplantation (LDLT) remain ambiguous when there is insufficient time to await a compatible organ. This study aimed to compare the results of adult ABOi HU-LDLT with those of adult ABO-compatible (ABOc) HU-LDLT utilizing data from the Korean Network for Organ Sharing (KONOS). METHODS: We conducted a retrospective study using KONOS data from 363 consecutive adult HU-LDLT patients between 2017 and 2021 in Korea. RESULTS: The incidence of ABOc-LDLTs and ABOi-LDLTs was 90.6% (n = 329) and 9.4% (n = 34), respectively. Hepatitis B virus infection and alcoholism are the main etiologies of adult HU-LDLT. The median waiting time was 1 day (range, 0-36 days) for ABOc LDLT patients and 3 days (range, 0-28 days) for ABOi LDLT patients. None of the patients developed antibody-mediated rejection during follow-up. The incidence of graft failure was 17.6% in ABOi LDLT patients and 7.6% in ABOc LDLT patients. However, the overall survival and graft survival rates in the ABOi LDLT patients were not different from those in the ABOc LDLT patients. ABOi LDLT was not associated with graft failure or death in multivariable analysis. CONCLUSION: The present study supports ABOi-LDLTs as a feasible and safe treatment for highly urgent patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationLiving DonorsABO Blood-Group SystemBlood Group IncompatibilityHumansFemaleMaleRetrospective StudiesAdultMiddle AgedRepublic of KoreaDatabases, FactualTreatment OutcomeGraft SurvivalAgedLiver Failure, Acute

Stichwörter der Autor:innen

Acute-on-Chronic Liver FailureComplicationsDonor SelectionEnd-Stage Liver DiseaseHepatorenal SyndromeLiver FailureLiving DonorsMechanical VentilationMortalitySurvival

Substanzen

ABO Blood-Group System

Autor:innen und Institutionen

  • Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. yjongman21@gmail.com.
  • Department of Surgery, Korea University College of Medicine, Seoul, Korea.
  • Division of Hepatobiliopancreas and Transplant Surgery, Korea University Ansan Hospital, Ansan, Korea.
  • Biomedical Statistics Center, Research Institute for Future Medicine, Samsung Medical Center, Seoul, Korea.
  • Department of Data Convergence and Future Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Department of Digital Health, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Korea.

ORCID-Profile: Jongman Kim, Sang Jin Kim, Boram Park, Kyunga Kim, YoungRok Choi, Geun Hong, Jun Yong Park, Young Seok Han, Nam-Joon Yi, Seung Heui Hong, Soon-Young Kim, Jungbun Park, Youngwon Hwang, Dong-Hwan Jung

Förderung

  • Ministry of Health and Welfare
  • National Research Foundation of Korea

Zitieren

APA

Kim, J., Kim, S. J., Park, B., Kim, K., Choi, Y., Hong, G., Park, J. Y., Han, Y. S., Yi, N. J., Hong, S. H., Kim, S. Y., Park, J., Hwang, Y., & Jung, D. H. (2026). Outcomes of Highly Urgent ABO-Incompatible Living Donor Liver Transplantation in National Databases. Journal of Korean Medical Science. https://doi.org/10.3346/jkms.2026.41.e46

Vancouver

Kim J, Kim SJ, Park B, Kim K, Choi Y, Hong G, et al. Outcomes of Highly Urgent ABO-Incompatible Living Donor Liver Transplantation in National Databases. Journal of Korean Medical Science. 2026. doi:10.3346/jkms.2026.41.e46

BibTeX
@article{Kim2026,
  author = {Kim, Jongman and Kim, Sang Jin and Park, Boram and Kim, Kyunga and Choi, YoungRok and Hong, Geun and Park, Jun Yong and Han, Young Seok and Yi, Nam-Joon and Hong, Seung Heui and Kim, Soon-Young and Park, Jungbun and Hwang, Youngwon and Jung, Dong-Hwan},
  title = {Outcomes of Highly Urgent ABO-Incompatible Living Donor Liver Transplantation in National Databases},
  journal = {Journal of Korean Medical Science},
  year = {2026},
  doi = {10.3346/jkms.2026.41.e46}
}
Kostenlos starten →